Cargando…
New science, drug regulation, and emergent public health issues: The work of FDA’s division of applied regulatory science
The U.S. Food and Drug Administration (FDA) Division of Applied Regulatory Science (DARS) moves new science into the drug review process and addresses emergent regulatory and public health questions for the Agency. By forming interdisciplinary teams, DARS conducts mission-critical research to provid...
Autores principales: | Chiu, Kimberly, Racz, Rebecca, Burkhart, Keith, Florian, Jeffry, Ford, Kevin, Iveth Garcia, M., Geiger, Robert M., Howard, Kristina E., Hyland, Paula L., Ismaiel, Omnia A., Kruhlak, Naomi L., Li, Zhihua, Matta, Murali K., Prentice, Kristin W., Shah, Aanchal, Stavitskaya, Lidiya, Volpe, Donna A., Weaver, James L., Wu, Wendy W., Rouse, Rodney, Strauss, David G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893027/ https://www.ncbi.nlm.nih.gov/pubmed/36743666 http://dx.doi.org/10.3389/fmed.2022.1109541 |
Ejemplares similares
-
Translating New Science Into the Drug Review Process: The US FDA’s Division of Applied Regulatory Science
por: Rouse, Rodney, et al.
Publicado: (2017) -
The FDA’s Diverse and Dynamic Activities in the Social and Behavioral Sciences: Advancing and Supporting Health Equity
por: Lee, Christine, et al.
Publicado: (2021) -
The effects of lobbying on the FDA’s recall classification
por: Zhou, Yifan
Publicado: (2023) -
Physician Perceptions of the FDA’s Breakthrough Therapy Designation: An Update
por: Paquin, Ryan S, et al.
Publicado: (2022) -
LAWS, REGULATIONS, AND POLICY: Genetically Engineered Salmon on the FDA’s Table
por: Taylor, David A.
Publicado: (2010)